tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Monopar Therapeutics price target raised to $109 from $74 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Monopar Therapeutics (MNPR) to $109 from $74 and keeps an Overweight rating on the shares.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1